期刊文献+

对氧磷酶的生物学特性及与疾病的关系 被引量:3

Paraoxonase Family's Biological Characters and Its Relationship with Diseases
下载PDF
导出
摘要 对氧磷酶(paraoxonase,PON)家族是由PON 1,PON 2,PON 3三大成员组成的。三者在分子结构、基因结构及生物学特性上都有很多相似性。对氧磷酶最重要的生物学特性是抗氧化性,这与许多疾病的发生发展有关。目前的研究已经肯定对氧磷酶具有抗心血管疾病(主要是动脉粥样硬化、冠心病)的作用,但是这种关系主要是由PON 1活性决定的,而与PON 1的基因多态性关系不大。对氧磷酶的活性与糖尿病(DM)及其并发症的发生呈负相关,但是其基因型与DM的关系还需要有更多的研究来证实。吸烟可以降低血清对氧磷酶的活性和浓度,酒精对PON的影响与酒精的摄入量有关,而维生素E等影响的研究结论尚不一致,需要进行更多的实验。 The paraoxonase family consists of three members (PON1 ,PON2 and PON3)that shape structural properties and enzymatic activities ,among which is the ability to hydrolyze oxidized llpids in LDL. There is a relationship between its antioxidant ability and many diseases. Lip to date ,it is proved that PON1 activity inhibits the development of cardio-vascular diseases such as arteriosclerosis (AS)and coronary heart disease (CHD). But the influence of PON gene polymorphlisms is still uncertain in the terms of diabetes mellitus. Besides gene polymorphlisms,smoking can decrease the concentration and activity of PON,while the influence of alcohol depends on its amount. In addition,more studies should be taken to identify the roles of factors such as vitamin E in regulating the paraoxonase,
作者 李园园 李萍
出处 《现代检验医学杂志》 CAS 2007年第3期91-94,共4页 Journal of Modern Laboratory Medicine
关键词 对氧磷酶 心血管疾病 糖尿病 阿尔茨海默病 paraoxonase cardio-vascular diseases diabetes mellitus Alzheimer Disease
  • 相关文献

参考文献6

二级参考文献36

  • 1尹建丽,孙亚威,仇玉明,尚可.对氧磷酯酶1与2型糖尿病并发冠心病相关因素分析[J].中国全科医学,2004,7(16):1129-1131. 被引量:2
  • 2各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33022
  • 3[2]Serrato M, Marian AJ.A variant of human paraoxonase/ arylesterase (HUMPONA) gene is a risk factor for coronary disease[J].J Clin Invest,1995,96:3005.
  • 4[3]Herrmann SM, Blanc H, Poirier O,et al. The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM study[J]. Atherosclerosis,1996,126: 299.
  • 5[4]Mackness MI,Mackness B,Durrington PN,et al.Paraoxonase and coronary heart disease[J].Curr Opin Lipidol,1998,9:319.
  • 6[5]Adkins S, Gan KN, Mody M, et al. Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes[J]. Am J Hum Genet, 1993, 52:598.
  • 7[6]Mackness MI, Arrol S,Mackness B,et al.The alloenzyme of para-oxonase determines the effectivness of HDL in protecting LDL against lipid preoxidation[J]. Lancet,1997,349:851.
  • 8[7]Sorenson RC,Primo-Parmo SL,Kuo CL,et al.Reconsideration of the catalytic center and mechanism of mammalian paraoxonase/ arylesterase[J]. Proc Natl Acad Sci USA,1995,92:7187.
  • 9[8]Humbert R,Adler DA,Disteche CM,et al. The molecular basis of the human serum paraoxonase activity polymorphism[J]. Nat Genet,1993,3:73.
  • 10[9]Furlong CE,Li WF,Costa LG,et al.Genetically determind suscept-ibility to organophsphorus insecticides and nerve agents: developing a mouse model for the human PON1 polymorphism[J]. Neurotoxicology,1998,19:645.

共引文献18

同被引文献26

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部